Sort
16,300 grants matching “fatty liver disease”
The Growth Hormone and Insulin-like Growth Factor-1 Axis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
$198,297Laura Elisabeth Dichtel · Massachusetts General Hospital · K23 · FY2021 · DK
The Growth Hormone and Insulin-like Growth Factor-1 Axis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
$198,297Laura Elisabeth Dichtel · Massachusetts General Hospital · K23 · FY2019 · DK
The Growth Hormone and Insulin-like Growth Factor-1 Axis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
$198,297Laura Elisabeth Dichtel · Massachusetts General Hospital · K23 · FY2018 · DK
Project 4 - Smita Ghare, PhD
$198,281Smita S Ghare · University Of Louisville · P20 · FY2025 · GM
A role for glycolipids and unconventional T cell subsets in alpha-gal allergy
$198,279Onyinye I Iweala · Univ Of North Carolina Chapel Hill · K08 · FY2023 · AI
Candidate Selection for Liver Transplantation in Patients with Alcohol-related Liver Disease
$198,180Po-Hung (victor) Chen · Johns Hopkins University · K23 · FY2022 · AA
Candidate Selection for Liver Transplantation in Patients with Alcohol-related Liver Disease
$198,180Po-Hung (victor) Chen · Johns Hopkins University · K23 · FY2021 · AA
Candidate Selection for Liver Transplantation in Patients with Alcohol-related Liver Disease
$198,180Po-Hung (victor) Chen · Johns Hopkins University · K23 · FY2020 · AA
Candidate Selection for Liver Transplantation in Patients with Alcohol-related Liver Disease
$198,180Po-Hung (victor) Chen · Johns Hopkins University · K23 · FY2023 · AA
Candidate Selection for Liver Transplantation in Patients with Alcohol-related Liver Disease
$198,180Po-Hung (victor) Chen · Johns Hopkins University · K23 · FY2024 · AA
Non-Coding Variants of Angiotensinogen Gene and Hypertension
$198,125Ashok Kumar Kumar · University Of Toledo Health Sci Campus · R01 · FY2016 · HL
Base editing of ASGR1 for cardiovascular disease
$198,125Renzhi Han · Indiana University Indianapolis · R21 · FY2023 · HL
Poxviruses and Pro-Resolving Lipids
$198,088Christopher Norbury · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2015 · AI
Investigating the Role of Hepatic Glucagon Receptor Signaling in Healthspan and Aging
$198,065Jennifer Helene Stern · University Of Arizona · R01 · FY2024 · AG
Biomimetic NanoVilli Chips for Extracellular Vesicles in Hepatocellular Carcinoma
$198,033Yazhen Zhu · University Of California Los Angeles · R21 · FY2020 · CA
Biosynthesis of Membrane Protein Glycolipid Anchors
$197,955Anant K Menon · Weill Medical Coll Of Cornell Univ · R01 · FY2009 · GM
DMB (3,3-dimethyl-1-butanol) as a novel translational strategy for preventing and treating gut dysbiosis-associated arterial aging
$197,803Douglas R Seals · University Of Colorado · R21 · FY2020 · AG
Alcohol metabolism in liver sinusoidal endothelial cells
$197,719Yasuko Iwakiri · Yale University · R21 · FY2016 · AA
Innovative Efficacy Measures of Lupus Nephritis Therapies
$197,694Hermine I Brunner · Cincinnati Childrens Hosp Med Ctr · U01 · FY2014 · AR
Metabolism Core
$197,543Elisabet Borsheim · Arkansas Children'S Hospital Res Inst · P20 · FY2019 · GM
Lifelong Triclosan Exposure and Fatty Liver Disease
$197,448Robert H Tukey · University Of California, San Diego · R21 · FY2021 · ES
Shifting paradigms to emerging toxins in freshwater cyanobacterial blooms
$197,381Matthew John Bertin · Case Western Reserve University · R21 · FY2023 · ES
Metabolic Syndrome after Pediatric Liver Transplant: Causes and Consequences
$197,364Emily Rothbaum Perito · University Of California, San Francisco · K23 · FY2017 · DK
Postnatal Complications and Interventions against Halogenated Organics during Pregnancy
$197,159Kevin Joseph Pearson · University Of Kentucky · P42 · FY2022 · ES
Postnatal Complications and Interventions against Halogenated Organics during Pregnancy
$197,159Kevin Joseph Pearson · University Of Kentucky · P42 · FY2021 · ES